Seino S
Second Department of Internal Medicine, Hirosaki University School of Medicine, Japan.
Nihon Jinzo Gakkai Shi. 1992 Apr;34(4):361-9.
Serum IgG antibodies to polyclonal IgA, IgA1 and IgA2 were evaluated by enzyme-linked immunosorbent assay in 50 patients with IgA nephropathy and 30 healthy controls to elucidate the relationship between IgA and IgG in IgA nephropathy. Anti-IgA antibody was considered positive if the titer exceeded the mean value in normal controls by greater than 2 SD. In patients with IgA nephropathy, 18 cases (36%) demonstrated anti-IgA antibody, 19 cases (38%) anti-IgA1 antibody and 7 cases (14%) anti-IgA2 antibody. Western blots confirmed the existence of anti-IgA antibody in these patients. There were no significant differences in serum IgA concentration, serum creatinine concentration, degree of hematuria, amount of urinary protein, and rate of glomerular IgG deposition between the "positive" group and "negative" group. Although the mechanism of production and the role of this antibody remain unknown, it may represent one of the diverse immune abnormalities of IgA nephropathy and may be involved in the pathogenesis of IgA nephropathy.
采用酶联免疫吸附测定法评估了50例IgA肾病患者和30名健康对照者血清中针对多克隆IgA、IgA1和IgA2的IgG抗体,以阐明IgA肾病中IgA与IgG之间的关系。如果滴度超过正常对照平均值2个标准差以上,则抗IgA抗体被视为阳性。在IgA肾病患者中,18例(36%)出现抗IgA抗体,19例(38%)出现抗IgA1抗体,7例(14%)出现抗IgA2抗体。蛋白质印迹法证实了这些患者中抗IgA抗体的存在。“阳性”组和“阴性”组在血清IgA浓度、血清肌酐浓度、血尿程度、尿蛋白量以及肾小球IgG沉积率方面无显著差异。尽管这种抗体的产生机制及其作用尚不清楚,但它可能代表了IgA肾病多种免疫异常之一,并且可能参与了IgA肾病的发病机制。